| Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis | |
| Li, Jing-Hua; Ma, Wei-Jie; Wang, Gang-Gang; Jiang, Xiang; Chen, Xi; Wu, Long; Liu, Zhi-Su; Zeng, Xian-Tao; Zhou, Fu-Ling; Yuan, Yu-Feng | |
| 刊名 | FRONTIERS IN IMMUNOLOGY
 |
| 2018 | |
| 卷号 | 9 |
| 关键词 | programmed cell death ligand-1 hepatocellular carcinoma prognosis clinicopathology meta-analysis |
| ISSN号 | 1664-3224 |
| DOI | 10.3389/fimmu.2018.02077 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4223488 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Li, Jing-Hua,Ma, Wei-Jie,Wang, Gang-Gang,et al. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis[J]. FRONTIERS IN IMMUNOLOGY,2018,9. |
| APA | Li, Jing-Hua.,Ma, Wei-Jie.,Wang, Gang-Gang.,Jiang, Xiang.,Chen, Xi.,...&Yuan, Yu-Feng.(2018).Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.FRONTIERS IN IMMUNOLOGY,9. |
| MLA | Li, Jing-Hua,et al."Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis".FRONTIERS IN IMMUNOLOGY 9(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论